Sandler Capital Management’s BioLife Solutions BLFS Stock Holding History

Sandler Capital Management’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-31,637	Closed	-$765K	–	128
2025 Q4	$765K	Buy	+31,637	New	+$828K	0.25%	121
2022 Q1	–	Sell	-58,761	Closed	-$2.19M	–	112
2021 Q4	$2.19M	Sell	58,761 -45,271	-44%	-$1.94M	0.19%	85
2021 Q3	$4.4M	Sell	104,032 -118,890	-53%	-$5.73M	0.39%	82
2021 Q2	$9.92M	Buy	222,922 +38,780	+21%	+$1.37M	0.77%	53
2021 Q1	$6.63M	Sell	184,142 -34,310	-16%	-$1.36M	0.57%	70
2020 Q4	$8.71M	Hold	218,452	–	–	1.02%	43
2020 Q3	$6.32M	Buy	218,452 +14,012	+7%	+$303K	0.64%	55
2020 Q2	$3.34M	Sell	204,440 -212,450	-51%	-$2.93M	0.32%	70
2020 Q1	$3.96M	Sell	416,890 -150,878	-27%	-$2.07M	0.55%	66
2019 Q4	$9.19M	Sell	567,768 -60,000	-10%	-$975K	1.05%	39
2019 Q3	$10.4M	Sell	627,768 -240,000	-28%	-$4.5M	0.91%	43
2019 Q2	$14.7M	Sell	867,768 -100,305	-10%	-$1.75M	0.98%	36
2019 Q1	$17.3M	Hold	968,073	–	–	1.35%	25
2018 Q4	$11.6M	Buy	968,073 +184,253	+24%	+$2.2M	0.99%	35
2018 Q3	$13.7M	Buy	783,820 +632,780	+419%	+$12.5M	0.69%	48
2018 Q2	$1.72M	Buy	+151,040	New	+$1.38M	0.14%	82

Other funds holding BLFS

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sandler Capital Management's BLFS Position: Q1 2026 in Review

Sandler Capital Management sold out of BioLife Solutions (BLFS) in Q1 2026, closing a stake of 31,637 shares — an estimated $765K sold.

Sandler Capital Management first reported a position in BLFS in Q2 2018 and held it in 16 quarters. The position peaked at $17.3M in Q1 2019. 187 funds tracked by Wall St. Rank hold BLFS as of Q1 2026.

Sandler Capital Management reported no remaining BioLife Solutions position as of Q1 2026 after selling out during the quarter.
Sandler Capital Management sold 31,637 BioLife Solutions shares in Q1 2026, an estimated $765K.
Sandler Capital Management first reported a position in BioLife Solutions in Q2 2018 and held it in 16 quarters.
Sandler Capital Management's BioLife Solutions position peaked at $17.3M in Q1 2019.
187 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2026.

Based on Sandler Capital Management's 13F filing for Q1 2026, filed 15 May 2026.